Literature DB >> 26691047

Comparison of the Icare rebound tonometry with the Goldmann applanation tonometry in a pediatric population.

Florin Grigorian1, A Paula Grigorian2, Ang Li3, Abdus Sattar4, Rohit Krishna5, Scott E Olitsky6.   

Abstract

We report the results of a comparative study at a single center on 214 eyes of 109 pediatric patients in whom IOP was measured using the Icare rebound tonometer and Goldmann applanation tonometry. Measurements from the two modalities demonstrated a correlation coefficient of 0.83 (P < 0.001), with Icare measuring on average 1.38 mm Hg higher. Compared to Goldmann, the Icare was more easily tolerated in the children studied. In 37 eyes that tolerated pachymetry, central corneal thickness was positively correlated with Icare measurements.
Copyright © 2015 American Association for Pediatric Ophthalmology and Strabismus. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26691047     DOI: 10.1016/j.jaapos.2015.08.009

Source DB:  PubMed          Journal:  J AAPOS        ISSN: 1091-8531            Impact factor:   1.220


  4 in total

1.  A Comparison of Applanation and Rebound Tonometers in Young Chicks.

Authors:  Lisa A Ostrin; Christine F Wildsoet
Journal:  Curr Eye Res       Date:  2020-07-03       Impact factor: 2.424

2.  Intraocular pressure monitoring by rebound tonometry in children with myopia.

Authors:  Jenchieh Weng; I-Lun Tsai; Li-Lin Kuo; Ching-Yao Tsai; Lin-Chung Woung; Ya-Chuan Hsiao
Journal:  Taiwan J Ophthalmol       Date:  2017 Jul-Sep

3.  Normal intraocular pressure in Egyptian children and meta-analysis.

Authors:  Ibrahim Rezkallah Moussa; Rehab Rashad Kassem; Noha Ahmed Edris; Dalia Hamed Khalil
Journal:  Eye (Lond)       Date:  2021-06-18       Impact factor: 4.456

4.  Results of First In Vivo Trial of an Acoustic Self-Tonometer.

Authors:  Jan Osmers; Oskar Hoppe; Alicja Strzalkowska; Piotr Strzalkowski; Ágnes Patzkó; Stefan Arnold; Michael Sorg; Andreas Fischer
Journal:  Transl Vis Sci Technol       Date:  2020-08-10       Impact factor: 3.283

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.